India · Delayed Price · Currency is INR Sanofi India Statistics
Total Valuation
Sanofi India has a market cap or net worth of INR 75.61 billion. The enterprise value is 72.07 billion.
| Market Cap | 75.61B |
| Enterprise Value | 72.07B |
Important Dates
The last earnings date was Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Nov 5, 2026 |
Share Statistics
Sanofi India has 23.03 million shares outstanding. The number of shares has decreased by -0.01% in one year.
| Current Share Class | 23.03M |
| Shares Outstanding | 23.03M |
| Shares Change (YoY) | -0.01% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 24.65% |
| Float | 9.07M |
Valuation Ratios
The trailing PE ratio is 20.74 and the forward PE ratio is 18.48.
| PE Ratio | 20.74 |
| Forward PE | 18.48 |
| PS Ratio | 4.15 |
| PB Ratio | 9.15 |
| P/TBV Ratio | 9.16 |
| P/FCF Ratio | 22.48 |
| P/OCF Ratio | 21.08 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.09, with an EV/FCF ratio of 21.42.
| EV / Earnings | 19.77 |
| EV / Sales | 3.96 |
| EV / EBITDA | 14.09 |
| EV / EBIT | 15.21 |
| EV / FCF | 21.42 |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.69 |
| Quick Ratio | 1.05 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.03 |
| Debt / FCF | 0.04 |
| Interest Coverage | 338.36 |
Financial Efficiency
Return on equity (ROE) is 40.27% and return on invested capital (ROIC) is 74.52%.
| Return on Equity (ROE) | 40.27% |
| Return on Assets (ROA) | 21.09% |
| Return on Invested Capital (ROIC) | 74.52% |
| Return on Capital Employed (ROCE) | 53.31% |
| Weighted Average Cost of Capital (WACC) | 4.87% |
| Revenue Per Employee | 16.60M |
| Profits Per Employee | 3.32M |
| Employee Count | 1,097 |
| Asset Turnover | 1.36 |
| Inventory Turnover | 3.16 |
Taxes
In the past 12 months, Sanofi India has paid 1.26 billion in taxes.
| Income Tax | 1.26B |
| Effective Tax Rate | 25.75% |
Stock Price Statistics
The stock price has decreased by -30.93% in the last 52 weeks. The beta is 0.11, so Sanofi India's price volatility has been lower than the market average.
| Beta (5Y) | 0.11 |
| 52-Week Price Change | -30.93% |
| 50-Day Moving Average | 3,085.99 |
| 200-Day Moving Average | 3,400.36 |
| Relative Strength Index (RSI) | 59.49 |
| Average Volume (20 Days) | 2,916 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi India had revenue of INR 18.22 billion and earned 3.65 billion in profits. Earnings per share was 158.27.
| Revenue | 18.22B |
| Gross Profit | 9.03B |
| Operating Income | 4.74B |
| Pretax Income | 4.91B |
| Net Income | 3.65B |
| EBITDA | 5.06B |
| EBIT | 4.74B |
| Earnings Per Share (EPS) | 158.27 |
Balance Sheet
The company has 3.69 billion in cash and 147.00 million in debt, with a net cash position of 3.54 billion or 153.71 per share.
| Cash & Cash Equivalents | 3.69B |
| Total Debt | 147.00M |
| Net Cash | 3.54B |
| Net Cash Per Share | 153.71 |
| Equity (Book Value) | 8.26B |
| Book Value Per Share | 358.69 |
| Working Capital | 3.95B |
Cash Flow
In the last 12 months, operating cash flow was 3.59 billion and capital expenditures -223.00 million, giving a free cash flow of 3.36 billion.
| Operating Cash Flow | 3.59B |
| Capital Expenditures | -223.00M |
| Depreciation & Amortization | 323.50M |
| Net Borrowing | -38.00M |
| Free Cash Flow | 3.36B |
| FCF Per Share | 146.07 |
Margins
Gross margin is 49.57%, with operating and profit margins of 26.01% and 20.01%.
| Gross Margin | 49.57% |
| Operating Margin | 26.01% |
| Pretax Margin | 26.95% |
| Profit Margin | 20.01% |
| EBITDA Margin | 27.78% |
| EBIT Margin | 26.01% |
| FCF Margin | 18.64% |
Dividends & Yields
This stock pays an annual dividend of 123.00, which amounts to a dividend yield of 3.75%.
| Dividend Per Share | 123.00 |
| Dividend Yield | 3.75% |
| Dividend Growth (YoY) | -35.94% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 77.71% |
| FCF Payout Ratio | 84.21% |
| Buyback Yield | 0.01% |
| Shareholder Yield | 3.75% |
| Earnings Yield | 4.82% |
| FCF Yield | 4.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Sanofi India is 4,339.67, which is 32.19% higher than the current price. The consensus rating is "Buy".
| Price Target | 4,339.67 |
| Price Target Difference | 32.19% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 5.66% |
| EPS Growth Forecast (3Y) | 7.08% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |